ID   MKNK2_RAT               Reviewed;         459 AA.
AC   Q5U2N4;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   24-JUL-2024, entry version 147.
DE   RecName: Full=MAP kinase-interacting serine/threonine-protein kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=MAP kinase signal-integrating kinase 2;
DE            Short=MAPK signal-integrating kinase 2;
DE            Short=Mnk2;
GN   Name=Mknk2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Serine/threonine-protein kinase that phosphorylates SFPQ/PSF,
CC       HNRNPA1 and EIF4E. May play a role in the response to environmental
CC       stress and cytokines. Appears to regulate translation by
CC       phosphorylating EIF4E, thus increasing the affinity of this protein for
CC       the 7-methylguanosine-containing mRNA cap. Required for mediating PP2A-
CC       inhibition-induced EIF4E phosphorylation. Triggers EIF4E shuttling from
CC       cytoplasm to nucleus. Enhances the formation of EIF4F complex in
CC       pachytene spermatocytes, thus promoting mRNA translation during
CC       spermatogenesis. Displays a high basal kinase activity. Acts as a
CC       mediator of the suppressive effects of IFNgamma on hematopoiesis.
CC       Negative regulator for signals that control generation of arsenic
CC       trioxide As(2)O(3)-dependent apoptosis and anti-leukemic responses.
CC       Involved in anti-apoptotic signaling in response to serum withdrawal
CC       (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Inhibited by CGP57380 and staurosporine.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Interacts with the C-terminal regions of EIF4G1 and
CC       EIF4G2; this interaction is promoted when MAPK pathways are repressed
CC       but repressed upon ERK proteins activation. Also binds to
CC       dephosphorylated MAPK3/ERK1 and MAPK1/ER2K. Interaction with
CC       phosphorylated MAPK3/ERK1 and MAPK1/ER2K protects it from
CC       dephosphorylation and inactivation. Interacts with ESR2 and EIF4E in
CC       the nucleus (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, PML body
CC       {ECO:0000250}.
CC   -!- PTM: Dual phosphorylation of Thr-244 and Thr-249 activates the kinase.
CC       Phosphorylation of Thr-379 activates the kinase. Phosphorylated upon
CC       arsenic trioxide As(2)O(3) treatment. Phosphorylated by MAPK1/ERK2,
CC       MAPK11 and MAPK14. Dephosphorylated by PP2A (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085941; AAH85941.1; -; mRNA.
DR   RefSeq; NP_001011985.1; NM_001011985.1.
DR   AlphaFoldDB; Q5U2N4; -.
DR   SMR; Q5U2N4; -.
DR   STRING; 10116.ENSRNOP00000039672; -.
DR   PhosphoSitePlus; Q5U2N4; -.
DR   PaxDb; 10116-ENSRNOP00000039672; -.
DR   Ensembl; ENSRNOT00000041106.6; ENSRNOP00000039672.3; ENSRNOG00000029028.6.
DR   Ensembl; ENSRNOT00055055061; ENSRNOP00055045506; ENSRNOG00055031813.
DR   Ensembl; ENSRNOT00060049239; ENSRNOP00060041096; ENSRNOG00060028286.
DR   Ensembl; ENSRNOT00065030769; ENSRNOP00065024481; ENSRNOG00065018329.
DR   GeneID; 299618; -.
DR   KEGG; rno:299618; -.
DR   UCSC; RGD:1305728; rat.
DR   AGR; RGD:1305728; -.
DR   CTD; 2872; -.
DR   RGD; 1305728; Mknk2.
DR   eggNOG; KOG0607; Eukaryota.
DR   GeneTree; ENSGT00940000154587; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q5U2N4; -.
DR   OMA; NKMTEVT; -.
DR   OrthoDB; 2899709at2759; -.
DR   PhylomeDB; Q5U2N4; -.
DR   TreeFam; TF314050; -.
DR   PRO; PR:Q5U2N4; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000029028; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0009931; F:calcium-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0071243; P:cellular response to arsenic-containing substance; ISO:RGD.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR050205; CDPK_Ser/Thr_kinases.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24349:SF254; MAP KINASE-INTERACTING SERINE_THREONINE-PROTEIN KINASE 2; 1.
DR   PANTHER; PTHR24349; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; ATP-binding; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Translation regulation; Zinc.
FT   CHAIN           1..459
FT                   /note="MAP kinase-interacting serine/threonine-protein
FT                   kinase 2"
FT                   /id="PRO_0000226965"
FT   DOMAIN          84..368
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          28..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           60..66
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           438..442
FT                   /note="MAP kinase binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        205
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         90..98
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         113
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         160..162
FT                   /ligand="staurosporine"
FT                   /ligand_id="ChEBI:CHEBI:57491"
FT                   /evidence="ECO:0000250"
FT   BINDING         209
FT                   /ligand="staurosporine"
FT                   /ligand_id="ChEBI:CHEBI:57491"
FT                   /evidence="ECO:0000250"
FT   BINDING         299
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         311
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         314
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CDB0"
FT   MOD_RES         244
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBH9"
FT   MOD_RES         249
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBH9"
FT   MOD_RES         379
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBH9"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CDB0"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CDB0"
FT   MOD_RES         446
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBH9"
FT   MOD_RES         450
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CDB0"
SQ   SEQUENCE   459 AA;  51574 MW;  7D26909FB98AC34D CRC64;
     MVQKRTAELQ GFHRSFKGQN PFELAFTLDP AQHGDSDFSP QCEARPDMPS SQPIDIPDAK
     KRGRKKKRCR ATDSFSGRFE DVYQLQEDVL GEGAHARVQT CVNLITNQEY AVKIIEKQLG
     HIRSRVFREV EMLYQCQGHR NVLELIEFFE EEDRFYLVFE KMRGGSILSH IHRRRHFNEL
     EASVVVQDVA SALDFLHNKG IAHRDLKPEN ILCEHPNQVS PVKICDFDLG SGIKLNGDCS
     PISTPELLTP CGSAEYMAPE VVEAFSEEAS IYDKRCDLWS LGVILYILLS GYPPFVGHCG
     SDCGWDRGEA CPACQNMLFE SIQEGKYEFP DKDWSHISFA AKDLISKLLV RDAKQRLSAA
     QVLQHPWVQG CAPENTLPTP LVLQRNSCAK DLTSFAAEAI AMNRQLAQCE EDAGQDQPVL
     IRATSRCLQL SPPSQSKLAQ RRQRASLSAT PVVLVGDRV
//
